EX-12.1 2 a07-5898_1ex12d1.htm EX-12.1

Exhibit 12.1

United Therapeutics Corporation
Ratio of Earnings to Fixed Charges
(Unaudited)

 

 

Years Ended December 31,

 

 

 

2006

 

2005

 

2004

 

2003

 

2002

 

 

 

(in thousands, except ratio)

 

Earnings (losses) from continuing operations before fixed charges

 

$

28,982

 

$

42,893

 

$

13,209

 

$

(11,526

)

$

(18,003

)

Fixed charges

 

 

 

 

 

 

 

 

 

 

 

Interest expenses, net of capitalized interest

 

$

482

 

$

29

 

$

3

 

$

112

 

$

117

 

Capitalized interest

 

—

 

—

 

—

 

—

 

—

 

Portion of rentals representative of interest factor

 

1,172

 

—

 

—

 

—

 

—

 

Total fixed charges

 

1,654

 

29

 

3

 

112

 

117

 

Ratio of earnings to fixed charges

 

17.52

 

1,479.07

 

4,403.00

 

—

 

—

 

Excess fixed charges over earnings

 

$

—

 

$

—

 

—

 

$

11,638

 

$

18,120

 

 

NOTE:  The Ratio of Earnings to Fixed Charges should be read in conjunction with the Consolidated Financial Statements and related Notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in United Therapeutics Corporation’s Annual Report on Form 10-K for the year ended December 31, 2006.